CLARUS THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Accounts Payable
CLARUS THERAPEUTICS HOLDINGS, INC. reported Increase (Decrease) in Accounts Payable of -$5.46 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2022-08-19
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2022-06-30 was -$5.57M.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2022-03-31 was $111.00K, a 97.28% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2021-12-31 was -$1.90M, a 437.12% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2021-09-30 was $2.38M.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2021 was $1.84M, a 76.22% decline from fiscal 2020.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2020 was $7.73M.
| Period end | Increase (Decrease) in Accounts Payable 1 month | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 7 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|---|---|
| 2022-06-30 | -$5.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | -$5.46M 10-Q · filed 2022-08-19 | -$7.36M derived: sum of 3 quarters · filed 2022-08-19 | -$4.98M derived: sum of 4 quarters · filed 2022-08-19 | ||||
| 2022-03-31 | $111.00K 10-Q · filed 2022-05-16 | -$1.79M derived: sum of 2 quarters · filed 2022-05-16 | $592.00K derived: sum of 3 quarters · filed 2022-05-16 | -$2.13M derived: sum of 4 quarters · filed 2022-08-19 | ||||
| 2021-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $481.00K derived: sum of 2 quarters · filed 2022-03-31 | -$2.24M derived: sum of 3 quarters · filed 2022-08-19 | $1.84M 10-K · filed 2022-03-31 | ||||
| 2021-09-30 | $2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | -$346.00K derived: sum of 2 quarters · filed 2022-08-19 | $3.74M 10-Q · filed 2021-11-19 | $4.30M derived: sum of 4 quarters · filed 2022-08-19 | ||||
| 2021-06-30 | -$2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $1.36M 10-Q · filed 2022-08-19 | -$40.13K 10-Q · filed 2021-08-16 | $1.92M derived: sum of 3 quarters · filed 2022-08-19 | ||||
| 2021-03-31 | $4.08M 10-Q · filed 2022-05-16 | -$74.95K 10-Q · filed 2021-05-26 | $4.64M derived: sum of 2 quarters · filed 2022-05-16 | |||||
| 2020-12-31 | $563.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $157.21K 10-K · filed 2021-05-06 | $7.73M 10-K · filed 2022-03-31 | |||||
| 2020-09-30 | $7.17M 10-Q · filed 2021-11-19 | |||||||
| 2020-06-30 | $761.00 10-Q · filed 2021-08-16 |